Scavestrogens protect IMR 32 cells from oxidative stress-induced cell death

Toxicology and Applied Pharmacology

Volumn 152, Issue 1, 1998, Pages 49-55

  Blum Degen, D ^a   Haas, M ^a   Pohli, S ^a   Harth, R ^a   Romer W ^b   Oettel, M ^b   Riederer, P ^a   Gotz M E ^a,c  

^a UNIVERSITY OF WÜRZBURG   (Germany)

^b BAYER PHARMA AG   (Germany)

^c KAROLINSKA INSTITUTE   (Sweden)

Author keywords

Alzheimer's disease; Fenton reagent; Glutathione; IMR 32 neuroblastoma; Oxidative stress; Radicals; Scavestrogens; Steroids

Indexed keywords

14ALPHA, 15ALPHA METHYLENE ESTRA 1,3,5(10),8 TETRAENE 3,17ALPHA DIOL; 17ALPHA ESTRADIOL; ANTIOXIDANT; ESTRA 1,3,5(10),8 TETRAENE 3,17ALPHA DIOL; ESTRADIOL; ESTRADIOL DERIVATIVE; FERROUS SULFATE; GLUTATHIONE; HYDROGEN PEROXIDE; J 811; J 861; SCAVENGER; SCAVESTROGEN SULFAMATE; THIOBARBITURIC ACID REACTIVE SUBSTANCE; TRYPAN BLUE; UNCLASSIFIED DRUG;

ARTICLE; CELL DEATH; CELL PROTECTION; CELL VIABILITY; CONTROLLED STUDY; HUMAN; HUMAN CELL; NEUROBLASTOMA CELL; OXIDATIVE STRESS;

EID: 0031738778     PISSN: 0041008X     EISSN: None     Source Type: Journal    
DOI: 10.1006/taap.1998.8503     Document Type: Article

References (40)

1. Ayres, S., Tang, M., and Subbiah, M. T. R. (1996). Estradiol-17β as an antioxidant: Some distinct features when compared with common fat-soluble antioxidants. J. Lab. Clin. Med. 128, 367-375.
2. Behl, C., Davis, J. B., Lesley, R., and Schubert, D. (1994). Hydrogen peroxide mediates amyloid-β-protein toxicity. Cell 77, 817-827.
3. Behl, C., Skutella, T., Lezoualc'h, F., Post, A., Widmann, M., Newton, C. J., and Holsboer, F. (1997). Neuroprotection against oxidative stress by estrogens: Structure-activity relationship. Mol. Pharm. 51, 535-541.
4. Behl, C., Widmann, M., Trapp, T., and Holsboer, F. (1995). 17-β estradiol protects neurons from oxidative stress-induced cell death in vitro. Biochem. Biophys. Res. Commun. 216, 473-482.
5. Butterworth, M., Lau, S. S., and Monks, T. J. (1997). Formation of catechol estrogen glutathione conjugates and γ-glutamyl transpeptidase-dependent nephrotoxicity of 17β-estradiol in the golden Syrian hamster. Carcinogenesis 18, 561-567.
6. Butterworth, M., Lau, S. S., and Monks, T. J. (1998). 2-Hydroxy-4-glutathione-S-yl-17β-estradiol and 2-hydroxy-1-glutathione-S-yl-17β-estradiol produce oxidative stress and renal toxicity in an animal model of 17β-estradiol-mediated nephrocarcinogenicity. Carcinogenesis 19, 133-139.
7. Darwish, H., Krisinger, J., Furlow, J. D., Smith, C., Murdoch, F. E., and DeLuca, H. F. (1991). An estrogen-responsive element mediates the transcriptional regulation of calbindin D-9K gene in rat uterus. J. Biol. Chem. 266, 551-558.
8. Diaz-Brinton, R., Tran, J., Profitt, P., and Montoya, M. (1997). 17β-estradiol enhances the outgrowth and survival of neocortical neurons in culture. Neurochem. Res. 22, 1339-1351.
9. Ferreira, A., and Caceres, A. (1991). Estrogen-enhanced neurite outgrowth: Evidence for a selective induction of tau and stable microtubules. J. Neurosci. 11, 392-400.
10. Good, P. F., Werner, P., Hsu, A., Olanow, C. W., and Perl, D. P. (1996). Evidence for neuronal oxidative damage in Alzheimer's disease. Am. J. Pathol. 149, 21-28.
11. Goodman, Y., Bruce, A., Cheng, B., and Mattson, M. P. (1996). Estrogens attenuate and corticosterone exacerbates excitotoxicity, oxidative injury, and amyloid-β-peptide toxicity in hippocampal neurons. J. Neurochem. 66, 1836-1844.
12. Götz, M. E., Dirr, A., Freyberger, A., Burger, R., and Riederer, P. (1993). The thiobarbituric acid assay reflects susceptibility to oxygen induced lipid peroxidation in vitro rather than levels of lipid hydroperoxides in vivo: A methodological approach. Neurochem. Int. 22, 255-262.
13. Götz, M. E., Künig, G., Riederer, P., and Youdim, M. B. H. (1994). Oxidative stress: Free radical production in neural degeneration. Pharmacol. Ther. 63, 37-122.
14. Green, P. S., Gridley, K. E., and Simpkins, J. W. (1996). Estradiol protects against β-amyloid (25-35)-induced toxicity in SK-N-SH human neuroblastoma cells. Neurosci. Lett. 218, 165-168.
15. Green, P. S., Gridley, K. E., and Simpkins, J. W. (1998) Nuclear estrogen receptor-independent neuroprotection by estratrienes - A novel interaction with glutathione. Neuroscience 84, 7-10.
16. Gridley, K. E., Green, P. S., and Simpkins, J. W. (1997). Low concentrations of estradiol reduce β-amyloid (25-35)-induced toxicity, lipid peroxidation and glucose utilization in human SK-N-SH neuroblastoma cells. Brain Res. 778, 158-165.
17. Jaiswal, A. K. (1994). Antioxidant response element. Biochem. Pharmacol. 48, 439-444.
18. Kawas, C., Resnick, S., Morrison, A., Brookmeyer, R., Corrada, M., Zonderman, A., Bacal, C., Donnell-Lingle, D., and Metter, E. (1997). A prospective study of estrogen replacement therapy and the risk of developing Alzheimer's disease: The Baltimore Longitudinal Study of Aging. Neurology 48, 1517-1521.
19. +-ATPase activity, glucose transport, and glutamate transport induced by amyloid β-peptide and iron. J. Neurosci. Res. 50, 522-530.
20. Krien, P. M., Margon, V., and Kermici, M. (1992). Electrochemical determination of femtomole amounts of free reduced and oxidized glutathione. J. Chromatogr. 576, 255-261.
21. Malins, D. C., Polissar, N. L., and Gunselman, S. J. (1996). Progression of human breast cancers to the metastatic state is linked to hydroxyl-radicalinduced DNA damage. Proc. Natl. Acad. Sci. USA 93, 2557-2563.
22. Mattson, M. P., Robinson, N., and Guo, Q. (1997). Estrogens stabilize mitochondrial function and protect neural cells against the pro-apoptotic action of mutant presenilin-1. NeuroReport 8, 3817-3821.
23. Miller, C. P., Jirkovsky, I., Hayhurst, D. A., and Adelman, S. J. (1996). In vitro antioxidant effects of estrogens with a hindered 3-OH function on the copper-induced oxidation of low density lipoprotein. Steroids 61, 305-308.
24. Mooradian, A. D. (1993). Antioxidant properties of steroids. J. Steroid Biochem. Mol. Biol. 45, 509-511.
25. Murphy, D. D., Cole, N. B., Greenberger, V., and Segal, M. (1998). Estradiol increases dendritic spine density by reducing GABA neurotransmission in hippocampal neurons. J. Neurosci. 18, 2550-2559.
26. Neill, D., Hughes, D., Edwardson, J. A., Rima, B. K., and Allsop, D. (1994). Human IMR 32 neuroblastoma cells as a model cell line in Alzheimer's disease research. J. Neurosci. Res. 39, 482-493.
27. Oettel, M., Römer, W., and Heller, R. (1996). The therapeutic potential of scavestrogens. Eur. J. Obstet. Gynecol. 65, 153. [Abstract]
28. Ohkawa, H., Ohishi, N., and Yagi, K. (1979). Assay for lipid peroxides in animal tissues by thiobarbituric acid reaction. Anal. Biochem. 95, 351-358.
29. Ohkura, T., Isse, K., Akazawa, K., Hamamoto, M., Yaoi, Y., and Hagino, N. (1995). Long-term estrogen replacement therapy in female patients with dementia of the Alzheimer type: 7 case reports. Dementia 6, 99-107.
30. Paganini-Hill, A., and Henderson, V. W. (1994). Estrogen deficiency and risk of Alzheimer's disease in women. Am. J. Epidemiol. 140, 256-261.
31. Regan, R. F., and Guo, Y. (1997). Estrogens attenuate neuronal injury due to hemoglobin, chemical hypoxia, and excitatory amino acids in murine cortical cultures. Brain Res. 764, 133-140.
32. 8,9-dehydro derivatives of 17α-estradiol and 17β-estradiol. Steroids 62, 304-310.
33. 9(11)-dehydro-17β-estradiol. Steroids 62, 688-694.
34. Ruiz-Larrea, B., Leal, A., Martin, C., Martinez, R., and Lacort, M. (1995). Effects of estrogens on the redox chemistry of iron: A possible mechanism of the antioxidant action of estrogens. Steroids 60, 780-783.
35. Sagara, Y., Dargusch, R., Klier, F. G., Schubert, D., and Behl, C. (1996). Increased antioxidant enzyme activity in amyloid β protein-resistant cells. J. Neurosci. 16, 497-505.
36. 2+. Arch. Biochem. Biophys. 347, 45-52.
37. Tang, M. X., Jacobs, D., Stern, Y., Marder, K., Schofield, P., Gurland, B., Andrews, H., and Mayeux, R. (1996). Effect of estrogen during menopause on risk and age at onset of Alzheimer's disease. Lancet 348, 429-432.
38. Toran-Allerand, C. D. (1996). Mechanisms of estrogen action during neural development-mediation by interactions with the neurotrophins and their receptors. J. Steroid Biochem. Mol. Biol. 56, 168-179.
39. Tumilowicz, J. T., Nichols, W. W., Cholan, J. J., and Greene, A. E. (1970). Definition of a continuous human cell line derived from neuroblastoma. Cancer Res. 30, 2110-2118.
40. Weaver, C. E., Park-Chung, M., Gibbs, T. T., and Farb, D. H. (1997). 17β-estradiol protects against NMDA-induced excitotoxicity by direct inhibition of NMDA receptors. Brain Res. 761, 338-341.